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Abstract
Apoptotic processes are important for physiologic renewal of an intact epithelial barrier and
contribute some antimicrobial resistance for bacteria and viruses, as well as anti-inflammatory
effects that benefits the mucosa. The oral cavity presents a model of host-bacterial interactions at
mucosal surfaces, in which a panoply of microorganisms colonizes various niches in the oral
cavity and creates complex multispecies biofilms that challenge the gingival tissues. This report
details gene expression in apoptotic pathways that occur in oral mucosal tissues across the
lifespan, using a nonhuman primate model. Macaca mulatta primates from 2 to 23 years of age (n
= 23) were used in a cross-sectional study to obtain clinical healthy gingival tissues specimens.
Further, mRNA was prepared and evaluated using the Affymetrix Rhesus GeneChip and 88
apoptotic pathway genes were evaluated. The results identified significant positive correlations
with age in 12 genes and negative correlations with an additional five genes. The gene effects
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were predicted to alter apoptosis receptor levels, extrinsic apoptotic pathways through caspases,
cytokine effects on apoptotic events, Ca+2-induced death signaling, cell cycle checkpoints, and
potential effects of survival factors. Both the positively and negatively correlated genes within the
apoptotic pathways provided evidence that healthy tissues in aging animals exhibit decreased
apoptotic potential compared to younger animals. The results suggested that decreased physiologic
apoptotic process in the dynamic septic environment of the oral mucosal tissues could increase the
risk of aging tissues to undergo destructive disease processes through dysregulated inflammatory
responses to the oral microbial burden.
Keywords
Aging; Apoptosis; Oral mucosa; Inflammation; Infection
Introduction
Mucosal surfaces of the body are under constant challenge from a wide array of
microorganisms, the complexity of which has only recently been fully appreciated through
the results of the Human Microbiome Project [1]. This lifelong challenge requires the
development of a range of immune response pathways, cells and biomolecules that are
required to maintain an effective homeostasis between the epithelial barrier and the
autochthonous microbiota. These interlinked systems of defense are also required to
discriminate between members of the commensal microbial ecology that contribute to
protection of the host, and the acquisition or emergence of pathogens within these ecologies.
Additionally, this constant “battle” between the mucosal bacteria and the host cells would be
expected to take a toll on the survival and function of both non-immune and immune cells
that inhabit mucosal tissues, such as those in the gingival tissues in the oral cavity. This
facet of the cell biology can be deduced from the short lifespan of epithelial cells, and the
importance of epithelial cell sloughing as a part of innate protection of the host. The
mucosal tissues are also enriched in cells undergoing the process of programmed cell death,
apoptosis [2]. This natural physiologic aspect of cell biology is critical in developmental
biology [3, 4], renewal of tissues in wound healing, elimination of auto-reactive cells, and
loss of mutated cells with neoplastic potential [5].Moreover, apoptotic processes appear
important for physiologic renewal of an intact epithelial barrier and contribute some
antimicrobial resistance, for both bacteria and viruses that benefits the mucosa [6]. Most
recently, evidence dictates that apoptosis is an essential mechanism that regulates the
immuno-inflammatory response against pathogens, through the generation of anti-
inflammatory signals affecting phagocytes at the site of the infection, as well as contributing
to the determination of the characteristics of the T helper response [2, 7, 8].
The oral cavity presents a model of host-bacterial interactions at mucosal surfaces in which
a panoply of microorganisms colonize various niches in the oral cavity [9] and create
complex multispecies biofilms that reflect environmental changes and disease processes in
the gingival tissues [10–13]. Furthermore, this model system enables routine sampling of
biological fluids and tissues that respond to these microbial changes, as well as likely
contributing to selective pressures that alter the ecology. We have reported previously that
examination of gene expression profiles in gingival tissues from young to aged nonhuman
primates, Macaca mulatta, demonstrated higher levels of pro-apoptotic and lower levels of
anti-apoptotic pathway genes in younger animals, with these patterns reversed in the aged
animals [14]. This implied that the apoptotic events were a normal activity in the gingival
tissues related to tissue renewal and health in this septic environment. An apparent decrease
in this process with aging would suggest a loss of capacity of the aged gingival tissue to
respond to the microbial challenge in a pathophysiologic fashion contributing to the increase
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in gingival disease and tissue destruction with aging [15–17]. Additional findings from our
studies demonstrated unique patterns of apoptotic gene expression and resulting biological
pathways with disease in adult compared to aged animals [14]. The interpretation being that
alterations in apoptosis occur in gingival health with aging that is even further disrupted
either resulting from the disease process, or contributing to the disease progression.
This report extends these observations, by specifically documenting a profile of genes in
apoptotic pathways that are significantly correlated with aging in healthy gingival mucosal
tissues. In addition, a number of these gene transcripts altered with aging interdigitate with
other biologic pathways that would be predicted to enhance a homeostatic host-bacterial
interaction, or contribute to a risk profile of the gingival tissues that could result in tissue
destruction in response to the chronic infection in the older animals.
Materials and methods
Nonhuman primate model and oral clinical evaluation
Rhesus monkeys (M. mulatta) (n = 23; 11 females and 12 males) housed at the Caribbean
Primate Research Center (CPRC) at Sabana Seca, Puerto Rico, were used in these studies.
Animals were selected by age based on the following criteria: ≤3 years (young; n = 5), 3–7
years (adolescent; n = 5), 12–16 years (adult; n = 8) and 18–23 years (aged; n = 5).
Nonhuman primates were fed a 20 %protein, 5 % fat, and 10 %fiber commercial monkey
diet (diet 8773, Teklad NIB primate diet modified: Harlan Teklad). The diet was
supplemented with fruits and vegetables, and water was provided ad libitum in an enclosed
corral setting.
A protocol approved by the Institutional Animal Care and Use Committee (IACUC) of the
University of Puerto Rico, enabled anesthetized animals to be examined for clinical
measures of periodontal including probing pocket depth (PD), and bleeding on probing
(BOP) as we have described previously [18].
Tissue sampling and gene expression microarray analysis—A buccal gingival
sample from a healthy site from the premolar/molar maxillary region of each animal was
taken using a standard gingivectomy technique, and maintained frozen in RNAlater solution.
Total RNA was isolated from each gingival tissue using a standard procedure as we have
described, and tissue RNA samples submitted to the microarray core to assess RNA quality
and analyze the transcriptome using the GeneChip® Rhesus Macaque Genome Array
(Affymetrix) [14, 19]. Individual samples were used for gene expression analyses.
Data analysis
For each gene, a simple linear regression model was fit to the scatter plot of expression by
age as a continuous variable. A p value ≤0.05 was used to evaluate the significance of the
correlation. Equivalently, this p value tests if the slope of the regression line is zero or not.
Genes whose expression showed significant correlation with age were mapped into the
Kyoto Encyclopedia of Genes and Genomes (KEGG) apoptosis pathway (www.genome.jp)
to develop an ontology analysis.
Results
A total of 17 genes involved in various apoptotic pathways, were found to be significantly
correlated with aging in healthy gingival tissues (Table 1). Figure 1 provides a KEGG
pathway summation of the genes in the various apoptotic pathways that were significantly
altered with aging in healthy gingival tissues and highlights the changes that generally
reflect an overall decrease in the capacity of cells in the aging tissues to undergo apoptosis.
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Figure 2 depicts the correlations among interleukin (IL)-1α, amiloride binding protein
1(ABP1)—orthologous to MyD88, inhibitor of kappa light polypeptide gene enhancer in B-
cells, kinase beta (IKBKB), V-rel avian reticuloendotheliosis viral oncogene-like protein
(RELA), baculoviral IAP repeat-containing 3 (BIRC3), and Bcl-2-related protein A1
(BCL2A1). These alterations in the transcriptome with aging represent elevated gene
expression patterns linked to the presence of an inflammatory stimulus (e.g., IL-1α) that are
anti-apoptotic and would be expected to increase cell survival and decrease normal cell
turnover. In addition, this figure includes the correlation curves for phosphoinositide-3-
kinase catalytic, gamma polypeptide (PIK3CG), protein kinase cAMP-dependent, catalytic,
beta (PRKACB), and protein kinase, cAMP-dependent, regulatory, type II, beta
(PRKAR2B). As can be noted in the KEGG pathway diagram, elevations in these genes and
products would also create a more anti-apoptotic environment and contribute to enhanced
cell survival. Figure 3 depicts the data regarding gene expression of caspase 10, apoptosis-
related cysteine protease (CASP10), Bcl-2-like 1 isoform 1 (BCL2L1), and DNA
fragmentation factor alpha polypeptide (DFFA).While increases in caspase 10 would be
expected to enhance extrinsic or mitochondria-independent apoptotic events in the tissue,
concomitant elevations in the BCL2L1, IAP (e.g., BIRC3, Fig. 1), and DFFA, which all
function as block points for apoptosis, would again be expected to favor an overall decrease
in apoptotic potential of cells in the aging gingival tissues.
In contrast to the previously described gene expression alterations that occurred in healthy
aged gingival tissues, select genes in the apoptotic pathways were significantly negatively
correlated with aging in these tissues. The TNF receptor superfamily, member 6 (FAS),
which is a major signal transducer for the adapter Fas-associated protein with death domain
(FADD) within the extrinsic pathway, decreases with age (Fig. 4). Similarly, calcineurin A
beta (CN) that is critical to the Ca+2-induced cell death pathway is decreased with aging,
thus potentially being a bottleneck in this pathway of apoptosis. Additionally, the ataxia
telangiectasia mutated (ATM) gene expression is significantly decreased with aging and
would be expected to minimize physiological apoptotic events that result from DNA damage
during cell cycling. Also, as shown in Fig. 4, gene expression of the insulin-like growth
factor receptor 1 (IGFR1) and tubulin tyrosine ligase-like family, member 4 (TTLL4)
demonstrate significant negative correlations with age in the gingival tissues. The IGFR1 is
frequently overexpressed in neoplastic cells, and mediates proliferation as an anti-apoptotic
molecule in the cells. TTLL4 is a member of a larger family of enzymes reported to have
polyglutamylase activity. The action of these enzymes has been linked to coordination of
chromatin remodeling with potential role as anti-proliferative and pro-apoptotic. Thus, its
decrease with aging would help to contribute to cellular activities in healthy aging tissues
that do not express normal physiologic apoptosis.
Discussion
Apoptosis is a process that results in cell death in the absence of inducing an inflammatory
response. Beyond being a central biological mechanism for maintaining tissue homeostasis
by balancing mitosis, alterations in the level of apoptotic events play a critical role in
multiple diseases including cancer, neurological disorders, cardiovascular disorders, and
autoimmune diseases [20]. Most recently, a role for apoptosis as a regulator of the immuno-
inflammatory response has also been shown. Thus, the detection and clearance of apoptotic
cells by phagocytes, occurs during the continual interaction of host cells with a diverse array
of microorganisms at mucosal surfaces, in order to maintain tissue homeostasis [21]. The
primary difference of ingestion of apoptotic cells versus engulfment of microbes by
phagocytes is the generation of an inflammatory response that is exclusively associated with
microbial phagocytosis. This biological feature is in contrast to an anti-inflammatory
phagocytic activity that occurs with ingestion of apoptotic cells [7, 22].
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In general, studies addressing the potential role of apoptosis in the chronic inflammation of
gingival tissues have shown increased expression of apoptosis biomolecules, that appear
primarily in phagocytic cells that have emigrated into the gingival tissues in response to
bacterial challenge [23]. However, the physiologic or pathophysiologic role of apoptosis in
the chronic inflammatory response and tissue destruction of periodontitis remains
inconclusive [24]. Historical data have indicated that a higher prevalence and more severe
periodontal disease occurs in aged individuals [25, 26]. However, the cellular and molecular
changes of the periodontium (including apoptotic events) associated with a higher
prevalence of oral diseases in aging remain unclear. Our initial report described that the
expression of genes in the apoptotic pathways are altered in aged healthy and periodontitis-
affected gingival tissue with regards to age using a nonhuman primate model of periodontitis
[14]. The results examining young, adult, and aged animals showed a generally lower
expression of anti-apoptotic and higher expression of pro-apoptotic genes associated with
healthy gingival tissue from young compared to aged animals.
This report expands on this data by identifying a set of genes in a larger group of nonhuman
primates including adolescents through correlation analysis, from within the larger cadre of
genes that comprise the range of extrinsic, cytokine, Ca+2 dependent, and survival signaling
aspects of apoptosis. Importantly, we found that variation in the expression of several
apoptotic genes was reproducible in this larger sample size, re-enforcing the concept that
survival pathways are up-regulated in aged-gingival tissues when compared with the young
counterpart, whereby gene expression of pro-apoptotic pathways were significantly reduced
with aging. Noteworthy, in this report new genes were identified to significantly correlate
with age in healthy gingival tissue (e.g., ABP1/MyD88, Fas, and ATM). We identified that a
pathway of response related to IL-1, and including MyD88 and the NF-κB transcription
activities was up-regulated with aging in the tissues. IL-1α is produced by many cell types
including constitutively by epithelial cells and induced in inflammatory cells, particularly
activated macrophages. It plays an important central role in the regulation of the immune
responses. In tissues, the release of IL-1α from dying cells can initiate sterile inflammation
by inducing recruitment of neutrophils, whereas another member of this cytokine family,
IL-1β, promotes the recruitment and retention of macrophages [27, 28]. The ABP1 is an
orthologous of MyD88 and is a membrane glycoprotein that is expressed in many
epithelium-rich and/or hematopoietic tissues. While it can catalyze degradation of a range of
polyamines involved in DNA synthesis and that are involved in allergic and immune
responses, it is also linked to cell proliferation and apoptosis [29, 30]. The inhibitor of kappa
light polypeptide gene enhancer in B-cells, kinase beta (IKBKB) phosphorylates the
inhibitor in the IκB/NF-κB complex, causing dissociation of the inhibitor and activation of
NF-κB. This process could have both pro- and anti-inflammatory activities, dependent upon
the downstream genes that are transcribed by binding NF-κB [31]. RELA also identified as
transcription factor p65 and is part of the NF-κB complex [32–35]. NF-κB is a transcription
factor, which is present in most cell types and is involved in diverse biological processes
such as inflammation, immunity, differentiation, cell growth, neoplastic changes, and
apoptosis. NF-κB complexes are maintained in the cytoplasm in an inactive state complexed
with inhibitors (I-κB family). In a conventional activation pathway, I-κB is phosphorylated
by I-κB kinases (IKKs) in response to different activators, subsequently degraded thus
liberating the active NF-κB complex, which translocates to the nucleus leading to
transcription of gene with NF-κB binding domains in their promoters. The BCL2A1
encodes a member of the BCL-2 protein family and acts as an anti-apoptotic regulator. The
protein reduces the release of pro-apoptotic cytochrome c from mitochondria and blocks
caspase activation, thus, retarding apoptotic events. Additionally, this gene is a direct
transcription target of NF-κB in response to inflammatory mediators such as TNFα and IL-1
that are increased with inflammation in gingival tissues [36, 37]. Finally, within the context
of the genes related to these pathways of regulation of apoptosis, the BIRC3 is a member of
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a family of inhibitors of apoptosis (IAP) that interfere with the activation of caspases. This
protein inhibits apoptosis induced by serum deprivation, but does not affect apoptosis
resulting from increases in free radicals. As importantly, with respect to responses in
gingival tissues apoptosis processes can be inhibited by binding to TRAF1/TRAF2 (TNF
receptor-associated factors) that are recruited to the TNFR2 (TNF receptor 2) and would
interfere with activation of IL-1β converting enzyme (ICE)-like proteases that are a family
of mammalian cysteine proteases [38]. Members of this family of proteases are believed to
be critical for mammalian cell apoptosis because inhibitors of ICE-like proteases can block
apoptosis [39]. This process appears to occur via binding of Fas ligand to Fas or TNFα to
the TNFR, which induce apoptosis. This is triggered by recruitment of an ICE-like protease
to the activated receptor [40, 41]. Of note, the substrates for ICE-like proteases are catalytic
proteins involved in homeostatic pathways in the cell, which suggests that undermining
cellular homeostasis is a basic feature that leads to irreversibility of the apoptotic process
and cell death [42].
Related to this cytokine pathway of anti-apoptosis, we identified fingerprints of gene
regulation that specifically targeted survival factor pathways in the tissues.
Phosphoinositide-3-kinase, catalytic, gamma polypeptide (PIK3CG) is a gene that encodes a
protein belonging to the pi3/pi4-kinase family of proteins. This enzyme phosphorylates
phosphoinositides and is crucial as an important modulator of extracellular signals. Thus,
not only does it contribute to the maintenance of the structural and functional integrity of
epithelia, but is a signal transducer to cellular engagement of molecules, such as nerve
growth factor (NGF) and IL-3 that provide signals for growth, maintenance, and survival of
cells, by interfering with intracellular pro-apoptotic molecules [43–45]. The actions of Pi3K
molecules synergize with the cAMP-dependent kinases in limiting apoptosis. The Protein
kinase, cAMP-dependent, catalytic, beta (PRKACB) is a catalytic subunit of protein kinase
A that mediates cAMP-dependent signaling triggered by receptor binding to G-protein-
coupled receptors (GPCRs) that comprise a transmembrane receptor family whose functions
are to sense molecules outside the cell and activate signal transduction pathways and cellular
responses [44, 46–50]. Binding of cAMP to the regulatory subunit of PKA, releases the
catalytic subunits, which then phosphorylate a diverse set of proteins, including transcription
factors, ion channels and metabolic enzymes. We also noted a relationship of increasing
level of protein kinase, cAMP-dependent, regulatory, type II, beta (PRKAR2B) mRNA with
aging in the gingival tissues. Four different regulatory subunits and three catalytic subunits
of PKA have been identified [50–52], with this being one of the regulatory subunits. This
subunit has been shown to interact with and suppress the transcriptional activity of the
cAMP-response element binding protein 1 (CREB1) in activated cells [53]. Results from
mice suggest that CREB1 may contribute to type 2 diabetes [54] and also appears to regulate
some aging-related genes like ATM [55]. Importantly, this combination of genes whose
expression is increased with aging in healthy gingival tissues is consistent with a more anti-
apoptotic environment in the aged tissues.
Caspase 10, apoptosis-related cysteine protease is one of a family of proteases whose
sequential activation plays a central role in the execution-phase of apoptosis. This protein
cleaves and activates caspases 3 and 7, and the protein itself is processed by caspase 8.
Mutations in this gene are associated with apoptosis defects in some autoimmune syndromes
[56]. It has been shown that caspase-10 can function in initiating Fas- and TNF-related
apoptosis-inducing ligand-receptor-mediated apoptosis [57]. As such, caspase 10 is recruited
to the native TRAIL death-inducing signaling complex (DISC) and to the native Fas (CD95)
DISC, and that FADD is necessary for recruitment and activation of these complexes [58].
Related to its potential role at mucosal surfaces, host cells engage in targeted antiviral
immune responses by inducing type I IFN and inflammatory cytokines via activation NF-κB
through cytoplasmic factors that recognize dsRNA generated during viral replication.
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Caspase-10 is involved in these pathways, since knockdown of caspase 10 in a human cell
line resulted in the reduction of inflammatory cytokine production in antiviral signaling [59].
Thus, the up-regulation of caspase 10 gene expression in aging tissues would be a benefit for
enhancing protection of the tissues from viral challenge, but could increase the opportunity
for the enzymatic apoptotic signaling cascade. However, also noted in the altered gene
expression profiles were increases in both Bcl-2-like 1 isoform 1 (BCL2L1), BIRC3 (IAP
containing), and DFFA. The BCL2L1 is another member of the Bcl family that can regulate
an array of cell functions. These proteins are located at the outer mitochondrial membrane,
and regulate mitochondrial membrane channel opening/potential that controls the production
of reactive oxygen species and release of cytochrome C [37]. Each of these is considered
potent inducers of cell apoptosis [60, 61]. As noted above, the BIRC3 is a member of a
family of IAP that interfere with the activation of caspases [62, 63]. Finally, DFFA is an
inhibitor of caspase-activated DNase [64]. The apoptotic process is accompanied by
shrinkage and fragmentation of cell nuclei and degradation of chromosomal DNA. DFFA is
the substrate for caspase 3 and a portion of the pathway that triggers DNA fragmentation
during apoptosis. DFFA when bound to DFFB, which triggers both DNA fragmentation and
chromatin condensation during apoptosis, inhibits the apoptotic fragmentation of DNA [65,
66]. However, when DFFA is cleaved by caspase-3, the cleaved fragments of DFFA
dissociate from DFFB, enabling action on the cellular DNA. Thus, the combination of
increases in the expression of these genes additionally supports an increased anti-apoptotic
environment in the aging gingiva, albeit, still enabling functional capacity for antiviral
responses to remain relatively intact.
While the above pathways of apoptosis would be expected to be altered via increases of anti-
apoptotic factors with aging, we also observed in this model a potential effect of selected
pro-apoptotic genes. The TNF receptor superfamily, member 6 (FAS) is a receptor
containing a death domain and plays a major role in the physiological regulation of
programmed cell death. This receptor-ligand engagement forms a DISC that includes
FADD, caspase 8, and caspase 10. This receptor has been also shown to activate NF-kB
[67]. Protein phosphatase 3, catalytic subunit, beta isoform (Calcineurin A beta; CN) is a
Ca+2- and calmodulin-dependent protein phosphatase [68]. Inactivating calcineurin slows
aging in Caenorhabditis elegans and the anti-aging effects of lowered calcineurin activity
decrease CREB transcriptional responses [53]. The decreased calcineurin would also lower
the Ca+2-induced pathway of apoptosis. This molecule also activates the T cells through the
transcription factor, nuclear factor of activated T cell (NFAT). As with NF-κB, the activated
NFAT is translocated into the nucleus and up-regulates the expression of IL-2, stimulating
growth and differentiation of T cells, thus influencing the characteristics and level of
immune responses [69–71]. Lastly, the ATM is a protein kinase that is recruited and
activated by DNA double-strand breaks. It phosphorylates proteins that initiate activation of
the DNA damage blockade that can trigger cell cycle arrest, DNA repair, or apoptosis [72,
73]. Consequently, the decreased levels of expression of these pro-apoptotic genes that
affect multiple pathways resulting in apoptosis would contribute to the overall anti-apoptotic
environment in aged gingival tissues. Interestingly, similar variations in the expression of
apoptotic genes shown in this study for healthy gingival tissues have also been reported in
oral squamous cellular carcinoma (OSCC) [74, 75]. Specifically, significant reduction in
ATM expression was found here in aged healthy gingival tissues and also in OSCC, when
compared with healthy control biopsies. Since ATM promotes apoptosis and suppresses
tumorigenesis through DNA damage detection, down-regulation of ATM could increase the
likelihood of aged oral mucosa demonstrating neoplastic changes.
Two additional genes that were significantly negatively correlated with aging in healthy
gingival tissues are less clear in how they contribute to differences in the tissue milieu
between younger and older individuals. Insulin-like growth factor 1 receptor (IGFR1) is a
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transmembrane receptor with kinase functions that is activated by insulin-like growth factors
1 and 2 and is frequently overexpressed by neoplasia, and mediates proliferation and
apoptosis protection. IGF1R activation protects cells from various apoptosis-inducing
extrinsic factors, including oxidative stress [76, 77] and the level appears to be an essential
determinant of resistance to apoptosis [78]. The IGF1R suppresses apoptosis primarily
through the PI3K pathway. It has also been suggested that the IGFR1 pathway could play an
important role in immune function, and lower levels or functions of this receptor may help
increase susceptibility to infection [79]. Thus, in the overall picture of the intracellular
apoptotic milieu, decreased levels of IGFR1 may be marginalized by the range of other gene
expression changes resulting in decreased apoptosis in aged tissues. The last gene whose
expression was observed to decrease significantly with aging was the TTLL4, which is a
polyglutamylase belonging to the larger TTLL family of proteins [80]. Polyglutamylation is
a new class of posttranslational modification in which glutamate side chains are formed in
proteins. TTLL4 appears to have some selective effect on histone chaperones, NAP1 and
NAP2 suggesting that TTLL4 could play a role in coordination of chromatin remodeling
[81]. Knockdown of TTLL4 or exogenous introduction of TTLL4 can enhance tumor cell
growth [82]. Thus, decrease in the expression of this gene in aging gingival tissues would be
consistent with an anti-apoptotic predilection for the cells.
These results suggested that apoptotic events normally occurring in gingival tissues could be
reduced with aging. Based on the anti-inflammatory and immunomodulatory role of
apoptosis and evidence showing the majority of apoptotic events occurring in the
inflammatory cellular infiltrate during periodontitis, it is tempting to hypothesize that in
contrast to young gingival tissues, reduced apoptotic responses in aged gingival tissues
could involve failure to control the inflammatory response against the chronic bacterial
challenge even in clinical healthy tissues. Unique aspects of apoptotic pathways are
potentially involved in the pathophysiology of periodontal disease in aging gingival tissues
that are predisposed to a dysregulated clearance of the inflammatory infiltrate. A better
understanding of the role of apoptosis in periodontal disease is clearly needed, which will
open new possibilities for therapeutic strategies oriented to re-establish the physiological
pro-apoptotic mechanisms in diseased gingival tissues, specifically within the inflammatory
cell population, as has been proposed for other chronic inflammatory disorders [83].
Age-related variations in apoptotic processes have also been reported in different human
tissues (e.g., skeletal muscles, neurons, spermatozoa, hepatocytes, intestinal epithelial cells,
and coronary arterial wall), whereby apoptotic events appear to increase or decrease in a
tissue-specific manner with aging [84–88]. Most recently, a reduced global apoptosis with
aging in humans was determined by serum levels of sFas, FasL and total cytochrome c,
which could increase the incidence of diseases whose pathophysiology involves apoptosis
dysregulation (e.g., cancer, arthritis and cardiovascular disease) [89]. The high phylogenetic
similarity of nonhuman primates to humans, provides an essential translational advantage to
understand the cellular and molecular changes of the host associated with aging (e.g.,
apoptosis), and how those changes could be risk modifiers for age-related diseases [90].
Therefore, future reproduction of these studies using human oral mucosa tissues would be
worthwhile.
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Fig. 1.
Aging-related variation in the expression of apoptotic genes in healthy oral mucosal tissues.
Apoptotic genes were identified and mapped using KEGG pathway analysis. Genes that
were significantly positively correlated with aging are highlighted in red and those that were
negatively correlated are highlighted in yellow. Expression of genes shown in purple was
unchanged at p ≤ 0.05 significance. +p = phosphorylation event; −p = de-phosphorylation
event
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Fig. 2.
Apoptotic genes related to cytokine signaling and subsequent intracellular pathways in
apoptotic processes that were significantly positively correlated with aging (p ≤ 0.05). The
correlation (r) and p-values are shown for each gene
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Fig. 3.
Apoptotic genes related to extrinsic pathway signaling in apoptotic processes that were
significantly positively correlated with aging (p ≤ 0.05). The correlation (r) and p-values are
shown for each gene
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Fig. 4.
Apoptotic genes that were significantly negatively correlated with aging (p ≤ 0.05). The
correlation (r) and p-values are shown for each gene
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Table 1
Apoptosis-related genes whose expression significantly correlated with age
Overexpressed genes in oral mucosal tissue with age Gene ID Probe ID
PRKAR2B protein kinase, cAMP-dependent, regulatory, type II, beta PRKAR2B MmugDNA.21586.1.S1
Phosphoinositide-3-kinase, catalytic, gamma polypeptide PIK3CG MmuSTS.1136.1.S1_at
DNA fragmentation factor, 45 kDa, alpha polypeptide DFFA MmuSTS.4221.1.S1_at
Orthologous to protein kinase, cAMP-dependent, catalytic, beta PRKACB MmugDNA.21559.1.S1_at
Orthologous to Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta IKBKB MmugDNA.8188.1.S1_at
Interleukin 1 alpha IL-1A Mmu.1167.1.S1_at
BIRC3 baculoviral IAP repeat-containing 3 BIRC3 Mmu.16393.1.S1_at
Amiloride binding protein 1—orthologous to (MyD88) ABP1 MmugDNA.10008.1.S1_at
Orthologous to Bcl-2-related protein A1 BCL2A1 MmugDNA.5658.1.S1_at
Caspase 10, apoptosis-related cysteine protease CASP10 MmugDNA.13788.1.S1_s_at
Similar to Bcl-2-like 1 isoform 1 BCL2L1 MmugDNA.12133.1.S1_at
V-rel avian reticuloendotheliosis viral oncogene-like protein RELA MmuSTS.3377.1.S1_at
Underexpressed genes in oral mucosal tissue with age Gene ID Probe ID
Orthologous to ataxia telangiectasia mutated ATM MmugDNA.12666.1.S1_at
Orthologous to protein phosphatase 3, catalytic subunit, beta isoform (Calcineurin A beta) PPP3CB MmugDNA.25748.1.S1_at
Orthologous to Insulin-like growth factor 1 receptor IGFR1 MmugDNA.12698.1.S1_at
Tubulin tyrosine ligase-like family, member 4 TTLL4 Mmu.9989.1.S1_s_at
TNF receptor superfamily, member 6 FAS MmuSTS.4665.1.S1_at
Apoptosis. Author manuscript; available in PMC 2014 March 01.
